Additionally, tirzepatide carries an FDA warning about acute gallbladder disease, which can present with similar abdominal symptoms
Mounjaro is not recommended in pregnancy, and this needs establishing before treatment rather than after
Key safety risks include hypoglycaemia when combined with insulin or sulphonylureas, gastrointestinal interactions, pancreatitis, gallbladder disease, and dehydration-related acute kidney injury
Right now, most information comes from short-term studies, clinical trials, and reports from users
A detailed medical history and lab review help minimize these risks
Genetic Variations in Your GLP-1 and GIP Receptors May Limit Response Your DNA holds clues about how efficiently your cells respond to GLP-1 and GIP signals